Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D

Summary: Novartis is spending $480 million to grow its business in China. They are upgrading a massive factory in Beijing and expanding their research center in Shanghai. This big move helps them make more medicines, including special radioactive drugs that fight cancer. Novartis is joining other big medicine companies, like AstraZeneca and Eli Lilly, who are also spending billions in China right now. The CEO of Novartis announced this plan to help treat more of their 80 million patients in the area.

For more details, see rssapp-fiercepharma-com at fiercepharma.com/pharma/after-lilly-az-pledges-novartis-commits-nearly-480m-boost-china-manufacturing-rd (opens in new tab)